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cytoskeletons. It seems likely that
WHAMM acts as a key spatial regulator
of ER exit sites in relation to the Golgi
complex.
Unlike the Golgi, the ER is spread
throughout the cytoplasm, and presum-
ably is shaped in tubes to provide a maxi-
mal surface-to-volume ratio. Nascent
transport vesicles could be helped in their
trafficking if they (or the sites from which
they emanate) have a specific link to their
target compartment: in this case, the
Golgi. Perhaps WHAMM functions in
a unique fashion to create local highways
to increase the efficiency of vesicle target-
ing while enabling cells to maintain dis-
tinct Golgi and ER distributions.
What links WHAMM to membranes?
WHAMM appears to be concentrated on
nascent transport vesicles—this suggests
that it may bind to the COP-II coat constit-
uents that form these structures. Other ac-
tin-cytoskeleton-associatedproteins inter-
act with COP-I vesicle components that
mediate transport from the Golgi back to
the ER. Moreover, clathrin coats also bind
to actin-regulatory proteins (cf. Kaksonen
et al., 2006). Further analysis of this inter-
esting protein will surely yield clues to the
interrelationships between the actin- and
microtubule-based cytoskeletons and
compartments of the secretory pathway.
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Figure 1. GFP-WHAMM May Reside
Primarily at ER Exit Sites
Shown is a captured frame fromMovie S1 of Cam-
pellone et al. (2008). This pattern is reminiscent of
ER exit sites, where cargo from the ER that is des-
tined for export is packaged into nascent vesicles.
Resident Golgi proteins that might be responsible
for the perinuclear localization of the Golgi do not
display such a punctate distribution.
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Three recent papers in Developmental Cell (by Yamamoto et al., Choi et al., and Sigismund et al.) show that
the endocytic route of internalization can determine whether signaling receptors are degraded or recycled,
and whether they initiate signaling from an endosomal platform. However, the same route can serve opposite
functions in different signaling pathways: there is no ‘‘unifying theory’’ of trafficking.Most cell signaling events begin when
secreted ligands bind transmembrane
receptors at the plasma membrane. Traf-
ficking of ligands (secretion) and recep-
tors (plasma membrane presentation
and endocytosis) is therefore key to cell-
to-cell communication, but it is also es-
sential to regulate the intensity and timing
of the signaling event. In a steady state,
cells produce receptors continuously
and need to compensate by degrading172 Developmental Cell 15, August 12, 2008them at a certain rate. Degradation occurs
in intracellular vesicular compartments,
but receptors can escape by recycling
back to the plasma membrane. This intri-
cate intracellular trafficking raises the
possibility that signal transduction events
downstream of the receptor are not taking
place at the plasma membrane, but en
route, while the ligand/receptor complex
traffics through distinct intracellular, en-
dosomal compartments.ª2008 Elsevier Inc.Based on these ideas distinct traffick-
ing routes and dedicated molecular ma-
chineries for receptor degradation or re-
cycling have been invoked for almost all
signaling pathways, and the existence of
intracellular signaling compartments has
been proposed (reviewed in Gonzalez-
Gaitan, 2003). Three papers in Develop-
mental Cell (Choi et al., 2008; Sigismund
et al., 2008; Yamamoto et al., 2008)
show that receptors in the EGF, Nodal,
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Previewsand Wnt signaling pathways each have
two alternative routes of internalization
mediating recycling/signaling versus deg-
radation. Interestingly, the route used by
one pathway for degradation is used by
another for signaling/recycling and vice
versa, implying that endocytic routes
may be interconnected, converging in
the early endosome and splitting again
to rejoin at the lysosome. Instead of linear
pathways, the different routes thus re-
semble the Garden of Forking Paths
(from Jorge Luis Borges).
Two endocytic routes are commonly
considered: clathrin-mediated and cla-
thrin-independent (reviewed in Conner
and Schmid, 2003; Mayor and Pagano,
2007). One clathrin-independent route is
mediated by lipid microdomains enriched
in sphingomyelin and cholesterol, which
correspond to the so-called lipid rafts that
may act as signaling platforms (Simons
and Ikonen, 1997). In the case of TGF-b
signaling, both pathways play a role (Di
Guglielmo et al., 2003). If the adaptor pro-
tein Sara is bound to TGF-b receptors at
the plasma membrane, receptors are di-
rected to the clathrin pathway and subse-
quently to a signaling compartment char-
acterized by the presence of Sara (Di
Guglielmo et al., 2003). Alternatively, if
Smad7 binds the receptor and recruits the
E3ubiquitin ligaseSmurf, then the receptor
is ubiquitinated, internalized through the
raft pathway, and routed to a caveolin-pos-
itive compartment for degradation.
A paper in the last issue of Develop-
mental Cell (Choi et al., 2008) uncovers
a role for Rap2 in diverting the TGF-b/
Nodal receptors from the degradation
pathway. The small GTPase Rap2 com-
petes with Smad7 for binding of recep-
tors. In the absence of ligand, Rap2
binding blocks receptor degradation in
lysosomes and directs it to recycling
through the Rab11 recycling endosomes.
In the presence of ligand, the receptor is
also diverted from degradation, but
instead of recycling, it signals.
Thus, in TGF-b/Nodal signaling, the cla-
thrin route promotes signal transduction
and the raft pathway degradation (Di Gu-
glielmo et al., 2003), with the choice being
made at the plasma membrane. Choi and
collaborators propose that Rap2 works
downstream, intracellularly, by deciding
whether the internalized cargo goes to re-
cycling or degradation (Choi et al., 2008).
Rap2 may represent a second decisionfork downstream of the clathrin or raft
pathways. Alternatively, the Rap2 site of
action could be, as for Sara and Smad7,
the plasma membrane.
Sigismund et al. (2008) show in the pres-
ent issueofDevelopmentalCell that inEGF
receptor (EGFR) signaling, clathrin also
promotes recycling/signaling, while raft
means degradation. In previous work
Sigismund et al. (2005) showed that the
concentration of the ligand EGF deter-
mines whether the receptor takes the
clathrin route (lowconcentration) or a com-
bination of the clathrin and a nonclathrin
route (corresponding to the raft route at
high EGF concentrations). The latter de-
pends, as with the TGF-b pathway, on
ubiquitination of the receptor, leading to
degradation mediated by multivesicular
endosomes and lysosomes (Sigismund
et al., 2005). Now Sigismund and col-
leagues show that the clathrin pathway
leads to recycling of the receptor and sus-
tained signaling (Sigismund et al., 2008),
asshownby theeffectsof clathrinpathway
blockage on phosphorylation of EGFR sig-
naling targets like AKT and ERK1/2. Inter-
estingly, phosphorylation of other targets,
such as Shc, does not require the clathrin
pathway, suggesting that clathrin endocy-
tosis does not generally equal signaling,
but rather activation of a particular subset
of branches in the signaling pathway. A
similar result was obtained long ago in
one of the founding studies of the field of
endocytosis and signaling (Vieira et al.,
1996): impairing dynamin-dependent en-
docytosis blocks some, but not all, targets
downstream of the EGFR.
The clathrin pathway thus supports
sustained EGFR signaling by directing
receptors to recycling. How? Recycling
may allow multiple cycles of signaling at
the plasma membrane and endosomes,
and protecting the receptors from degra-
dation or recycling may bring the recep-
tors to plasma membrane regions where
localized signaling occurs (e.g., for actin
dynamics or cell motility) or to environ-
ments where molecules can be stored
for signaling.
The Sigismund et al. paper also shows
that regardless of the route taken (clathrin-
dependent or -independent), the EGFR
traffics to the same type of compartment,
an EEA-1-positive early endosome. How-
ever, receptors seem to remember and
to be committed to the path they took at
the plasma membrane. Although recep-Developmental Cell 1tors taking the clathrin-independent path-
way join receptors internalized by clathrin
at theEEA-1 compartment, they ultimately
end up in the lysosome for degradation.
These findings present a dilemma. If sort-
ing can happen at the early endosome,
why split the routes at the plasma mem-
brane? Or, why mix previously sorted
cargo in an EEA-1 compartment? Perhaps
the cell decides the fate of receptors at the
membrane by ‘‘sensing’’ ligand concen-
trations, but the system is limited by the
availability of intracellular compart-
ments—everything must go through the
EEA-1 sorting station.
The TGF-b and EGFR pathways are
analogous in having degradation in the
raft route and signaling in the clathrin
route. A recent paper from Yamamoto
et al. (2008) shows the opposite for
Wnt3a: signaling by its receptor LRP6
happens in the raft route and degradation
in the clathrin route, consistent with the
widely held view that the raft compart-
ment works as a signaling platform
(Simons and Ikonen, 1997). In the pres-
ence of Wnt3a, LRP6 is phosphorylated
and internalized into a raft-dependent
caveolin-positive vesicular compartment,
where it can stabilize b-catenin and trans-
duce the signal. Phosphorylation requires
trafficking of the receptor to the caveolin-
positive compartment (where its kinase,
CK1g, is found), but not internalization of
the caveolin membrane microdomain.
However, signal transduction (i.e., b-cate-
nin stabilization) requires both phosphor-
ylation and endocytosis, suggesting
signaling from endosomes.
Besides Wnt3a, LRP6 can also bind a
Wnt3a antagonist, Dickkopf (Dkk), which
diverts it from the caveolin to the clathrin
pathway. Signal transduction does not
happen in that environment, because of
the absence of the kinase and the diver-
sion from the signaling compartment.
These stories suggest that animal cells
devote energy and design machineries
to the Yin-Yang of sorting molecules for
signaling versus degradation. Moreover,
trafficking routes resemble streets in
a city—they are not pathways, but rather
networks with many ways of getting to
a destination; some are faster, others are
shorter, others more efficient or pleasant.
The studies also suggest that although
sorting occurs at the plasma membrane,
it also happens again and again in down-
stream trafficking steps. Finally, each5, August 12, 2008 ª2008 Elsevier Inc. 173
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Previewssignaling pathway has its own strategy. It
may therefore prove difficult to formulate
or express a ‘‘unifying theory’’ of traffick-
ing during signaling.
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Aberrant microRNA (miRNA) expres
cer. Treatment of such disorders us
miRNA regulation in vivo. A recent p
genesis and maturation, elucidating
via posttranscriptional regulation o
Current analyses predict approximately
700 human miRNAs, and several hundred
more may exist. These miRNAs are likely
to regulate thousands of human genes.
Many miRNAs are expressed in tissue-
specific patterns and function in differenti-
ation andmorphogenesis of those tissues.
Misexpression of suchmiRNAs frequently
results in aberrant development.Given the
importance of precisely controllingmiRNA
function, there is significant interest in
characterizing factors required to regulate
miRNA gene expression.
MicroRNAs comprise a single class of
small, noncoding regulatory RNAs, which
are most easily distinguished by their
mode of biogenesis (Figure 1; reviewed
in Murchison and Hannon, 2004). They
are encoded by genes in animals, plants,
and viruses and are transcribed primarily
by RNA polymerase II. A primary miRNA
(pri-miRNA) transcript contains an in-
verted repeat that folds into a short hair-
pin. The hairpin is cleaved from the rest
of the transcript by the nuclear Micropro-
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cessor complex, which includes the RN-
ase III enzyme DROSHA, DGCR8, and
the associated RNA helicases p68 and
p72. The resulting pre-miRNA hairpin
product is exported from the nucleus to
the cytoplasm via interaction with the
nuclear export protein Exportin-5. In the
cytoplasm, Dicer processes the pre-
miRNA hairpin into a 21–24 nucleotide
duplex RNA and subsequently aids in
the assembly of the miRNA effector com-
plex, the miRNA-induced silencing com-
plex (miRISC). Active miRISC contains
only one of the two RNA strands, either
themature miRNA or the mature miRNA(*)
species, which guides effector complex
interaction with target messenger RNAs
via complementary base pairing. While
recent work has elucidated factors re-
quired for the transcriptional control of
miRNAs and the downstream effect of
mature miRNAs on their targets, the regu-
lation of miRNA biogenesis by cellular
events that produce miRISC is less well
understood.
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such as cardiac disorders and can-
quires a thorough understanding of
s our understanding of miRNA bio-
signaling directs cell differentiation
Recently, the miRNA miR-21 has come
under scrutiny and provided us with some
surprising revelations. It was shown
previously that miR-21 expression is sig-
nificantly upregulated in damaged cardio-
vascular tissue (Ji et al., 2007). In Davis
et al., 2008, a new study published in
Nature, the authors demonstrate that
miR-21 upregulation is a consequence
of TGF-b superfamily signaling during
normal development and homeostasis of
the vasculature. Moreover, they show
that TGF-b superfamily signaling controls
the miRNA processing machinery to
achieve upregulation of miR-21.
It is well established that the TGF-b su-
perfamily of growth factors directs vascu-
lar development and homeostasis, includ-
ing induction of the contractile phenotype
in human vascular smooth muscle cells
(VSMCs), by increasing the expression
of VSMC genes (Lagna et al., 2007). Davis
et al. explored the role of miR-21 in VSMC
differentiation by neutralizing miR-21
function using 20-O-methyl antagomirs.
